Tessari Eben 4
4 · Kiniksa Pharmaceuticals International, plc · Filed Dec 1, 2025
Insider Transaction Report
Form 4
Tessari Eben
CHIEF STRATEGY OFFICER
Transactions
- Exercise/Conversion
Class A Ordinary Share
[F1]2025-11-26$22.89/sh+200$4,578→ 22,914 total - Sale
Class A Ordinary Share
[F1]2025-11-26$42.89/sh−200$8,578→ 22,714 total - Exercise/Conversion
Share Option
[F1][F2]2025-11-26−200→ 46,938 totalExercise: $22.89Exp: 2031-03-15→ Class A Ordinary Share (200 underlying)
Footnotes (2)
- [F1]This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on April 29, 2024.
- [F2]The option is fully vested and exercisable.
Signature
/s/ Douglas Barry, Attorney-in-Fact|2025-12-01